CMAB Biopharma (Suzhou) Inc, a full-service contract development and manufacturing organisation, has named Maggie Chen as its new chief financial officer, it was reported on Thursday.

Chen has around 20 years of experience in listing, merger and acquisition, group comprehensive financial management and capital operation.

Prior to joining the company, Chen held the position of vice president and CFO of FOSUN Pharma Group. She has also served as CFO of Porton Pharma Solutions Ltd and was a senior auditor in PwC Accounting Firm; served in ACTARIS, and a subsidiary of Hong Kong TOM Group, in a financial management position.